Photoeradication and imaging of atheromatous plaque with texaphyrins

Proceedings of SPIE - The International Society for Optical Engineering

Volumn 2970, Issue , 1997, Pages 44-50

  Woodburn, Kathryn W ^a   Qing, Fan ^a   Kessel, David ^b   Young, Stuart W ^a  

^a PHARMACYCLICS INC   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiovascular disease; Fluorescence detection; Lutetium texaphyrin; Photodynamic therapy; Texaphyrin

Indexed keywords

CARDIOVASCULAR SURGERY; COMPUTER PERIPHERAL EQUIPMENT; FLUORESCENCE; INTERFACES (COMPUTER); LIGANDS; LUTETIUM; OPTICAL MATERIALS; PATIENT TREATMENT; PHOTOSENSITIZERS; PLASMONS; POLYMORPHISM; SURGERY;

CANCEROUS LESIONS; CARDIOVASCULAR DISEASE; FLUORESCENCE DETECTION; FLUORESCENCE IMAGING; IN-VIVO; MACROCYCLE; PATIENT DIAGNOSES; RED LIGHTS; SELECTIVE ERADICATIONS; TEXAPHYRIN; TREATMENT PLANNING;

PHOTODYNAMIC THERAPY;

EID: 58049146510     PISSN: 0277786X     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1117/12.275065     Document Type: Conference Paper

References (25)

1. Henderson, B.W., and T.J. Dougherty (1992) "How does photodynamic therapy work?" Photochem. Photobiol., 55; 145-157.
2. Pass, H. I. (1993) "Photodynamic therapy in oncology: mechanisms and clinical use," JNCI, 85; 443-456.
3. Young, S.W., M.K. Sidhu, Q. Fan, H.H. Muller, M. Neuder, G. Zanassi, T.D. Mody, G. Hemmi, W. Dow, J.D. Mutch, J.L. Sessler and R.A. Miller (1994) "Preclinical evaluation of gadolinium (III) complex. A new paramagnetic contrast agent for magnetic resonance imaging," Invest. Rad, 29; 330-338.
4. Sessler, J.L., G. Hemmi, T.D. Mody, T. Murai, A. Burrell and S.W. Young (1994) "Texaphyrins: Synthesis and applications," Acc. Chem. Res, 27; 43-50.
5. Young, S.W., Q. Fan, A. Harriman, J.L. Sessler, W.C. Dow , T.D. Mody, G. Hemmi, Y. Hao and R.A. Miller (1996) "Gadolinium(llI) texaphyrin: A tumor selective radiation sensitizer that is detectable by MRI," Proc. Natl. Acad. Sci. USA, 93; 6610-6615.
6. Rosenthal, D.I., Becerra, C.R., Nurenberg, P. et al. (1996) "Phase I study of gadolinium texaphyrin as an MRI contrast and radiosensitizer agent," Proceedings of ASCO, 15; 1663.
7. Woodburn, K.W., S.W. Young, Q. Fan and R.A. Miller (1996) "Selective uptake of texaphyrins by atheromatous plaque," Proc.SPIE, 2671; 62-71.
8. Young, S.W., K.W. Woodburn, M. Wright, T.D. Mody, Q. Fan, J.L. Sessler, W.C. Dow and R.A. Miller (1996) "Lutetium texaphyrin (PCI-0123): A near-infrared, water-soluble photosensitizer," Photochem. Photobiol., 63; 892-897.
9. Woodburn, K.W., Q. Fan, D. Kessel, M. Wright, T.D. Mody, G. Hemmi, D. Magda, J.L. Sessler, W.C. Dow, R.A. Miller and S.W. Young (1996) "Phototherapy of cancer and atheromatous plaque with texaphyrins," J. Clinical Laser Medicine and Surgery, 14; 343-348.
10. Woodburn, K.W., Q. Fan, D.R. Miles, D. Kessel, Y. Luo and S.W. Young (In press) "Localization and efficacy analysis of the phototherapeutic lutetium texaphyrin (PCI-0123) in the murine EMT6 sarcoma model," Photochem. Photobiol.
11. Wilson, B.C. (1989) "Photodynamic therapy: light delivery and dosage for second-generation photosensitizers." In Photosensitising Compounds: Their Chemistry, Biology and Clinical Use, (Edited by G. Bock and S. Harnett), Ciba Foundation Symposium 146, pp. 60-73, Wiley, Chichester.
12. Anderson, R.R., and J.A. Parrish (1981) "The optics of human skin," J. Investigative Dermatology, 77; 13-19.
13. Nolte C.J.M., A.M. Tercyak, H.M. Wu and D.M.Small (1990) "Chemical and physiological comparison of advanced atherosclerotic lesions of similar size and cholesterol content in cholesterol-fed New Zealand white and Watanabe heritable hyperlipidemic rabbits," Laboratory Investigations, 62;213-222.
14. Jayo, J.M., D.C. Schwenke and T.B. Clarkson (1994) "Atherosclerosis research." In The Biology of the Laboratory Rabbit, P.J. Manning, D.H. Ringler and C.E. Newcomer (eds.). San Diego: Academic Press, pp. 367-380.
15. Garini, Y., N. Katzir, D. Cabib, R.A. Buckwald, D.G. Soenksen and Z. Malik (1996) "Spectral Bioimaging," In Fluorescence Imaging Spectroscopy and Microscopy. X.F. Weng and B. Herman (eds.). John Wiley and Sons, Inc. New York. pp. 87-124.
16. Reynolds, T. (1997) "Photodynamic therapy expands its horizons," JNCI, 89; 112-114.
17. Woodburn, K.W., F. Qing, D.R. Miles, D. Kessel and S.W. Young (1996) "Biological analysis of lutetium texaphyrin (PCI-0123)," Photochem. Photobiol., 80S; 63S.
18. Schrock, E., S. du Manoir, T. Veidman, B. Schoell, J. Wienberg, M.A. Ferguson-Smith, Y. Ning, D.H. Ledbetter, I. Bar-Am, D. Soenksen, Y. Garini and T. Reid (1996) "Multicolor spectral karyotyping of human chromosomes," Science, 273; 494-497.
19. Narciso, H.L., W-F Cheong, R. Crilley, D.R. Doiron and J.R. Spears (1994) "Retention of tin ethyl etiopurpurin (SnET2) by atheromatous plaques: Studies in vitro and in vivo rabbit," SPIE, 2130; 30-41.
20. Hsiang, Y.N., M.T. Crespo, A.M. Richter, A.K. Jam, M. Fragoso and J.G. Levy (1993) "In vitro and in vivo uptake of benzoporphyrin derivative into human and miniswine atherosclerotic plaque," Photochem. Photobiol., 57; 670-674.
21. Hsiang, Y.N., M. Fragoso, V. Tsang and W. Schreiber (1993) "Determining the optimal dose of Photofrin® in miniswine atherosclerotic plaque," Photochem. Photobiol., 57; 518-525.
22. Vincent, G.M., J. Fox, G. Chariton, J.S. Hill, R. McClane and J.D. Spikes (1991) "Presence of blood significantly decreases transmission of 630 nm laser light," Lasers Med. Sci., 11;399-403.
23. Spears, J.R. (1989) "Photosensitization," In Cardiovascular laser therapy," Isner, J.M. and R.H. Clarke (eds). Raven Press Ltd, New York, NY, pp. 107-120.
24. Berliner, J.A., and J.W. Heinecke (1996) "The role of oxidized lipoproteins in atherogenesis," Free Radical Biology & Medicine, 20; 707-727.
25. Acton, S., A. Rigotti, K.T. Landschulz, S. Xu, H.H. Hobbs and M. Krieger (1996) "Identification of scavenger receptor SR-BI as a high density lipoprotein receptor," Science, 271;518-520.